National Health Act 1953 - Amendment determination under paragraph 98C(1)(b) - conditions (No. PB 39 of 2010)

Overview

The National Health Act 1953, amended in 2010, provides the legislative framework for the Pharmaceutical Benefits Scheme (PBS), through which the Commonwealth ensures Australians have access to affordable and timely medicines. This Act establishes the conditions under which the Commonwealth will provide benefits for pharmaceutical items, as well as the procedures for the Minister to determine these benefits. The 2010 amendment, in particular, responds to recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC) to adjust the conditions governing payments for the supply of pharmaceutical benefits by approved pharmacists and medical practitioners. This amendment reflects a policy objective to maintain the effectiveness and efficiency of the PBS by regularly reviewing and updating the criteria and conditions based on expert advice and evolving healthcare needs. The enacting body for this amendment is the Australian Government, through the Minister for Health, who has the authority to determine the conditions under which pharmaceutical benefits are supplied under the Act.

Scope and Application

The National Health Act 1953, as amended by the legislative instrument PB 39 of 2010, applies to the supply of pharmaceutical benefits under the Pharmaceutical Benefits Scheme (PBS). The Act governs the conditions under which the Commonwealth provides payments for the supply of these benefits by approved pharmacists and approved medical practitioners. The Minister for Health has the authority to determine these conditions, as outlined in section 98C(1)(b) of the Act. This legislative instrument specifically amends the determination made by PB 119 of 2008, effective from 1 May 2010, to reflect changes recommended by the Pharmaceutical Benefits Advisory Committee (PBAC). The changes include the addition of a listed drug, Lacosamide, to the schedule of drugs eligible for Commonwealth payments under the PBS. The amendments apply nationally and affect all approved pharmacists and medical practitioners supplying pharmaceutical benefits within Australia. There are no stated exclusions or exemptions in this particular instrument, although the Act itself may have provisions that exclude certain drugs or conditions from eligibility. The application of the Act is further extended or restricted through subordinate instruments, such as determinations and legislative instruments, which detail specific conditions and drugs.

Key Provisions

The main operative sections of this legislative instrument (paragraphs 1 and 2) detail the commencement date of the amendment and the amendment to the previous legislative instrument, PB 119 of 2008, which was made effective on 1 December 2008. Schedule 1, which forms part of this instrument, further specifies the changes to the conditions under which payments will be made for the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners. This amendment follows recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC) and is set to take effect from 1 May 2010, as indicated in paragraph 1. The obligations imposed by this Act on the parties involved include the requirement for the Minister to determine the conditions under which payments will be made by the Commonwealth for pharmaceutical benefits supplied by approved pharmacists and approved medical practitioners. These conditions are crucial for ensuring that the Pharmaceutical Benefits Scheme (PBS) operates effectively and efficiently. The Minister's role is pivotal in setting these conditions to align with the scheme's objectives of providing reliable, timely, and affordable access to medicines for all Australians. The determinations also encompass the forms of listed drugs, the manner of administration, and the brands of pharmaceutical items that qualify for benefits under the PBS, ensuring clarity and consistency in the administration of the scheme. In terms of offences, penalties, or consequences for breach, the Act does not explicitly detail specific criminal or civil penalties for non-compliance with the conditions set by the Minister. However, failure to adhere to the stipulated conditions could potentially lead to non-payment of benefits by the Commonwealth, thereby impacting the approved pharmacists and approved medical practitioners who rely on these payments. Additionally, non-compliance with the PBS regulations could lead to administrative actions, including investigations and potential fines or sanctions imposed by relevant health authorities. The exact penalties would depend on the specific nature of the breach and the jurisdiction under which it falls, with the potential for penalties to be determined by administrative or civil courts.